Clinical trials for Dystrophic epidermolysis bullosa
19 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT06594393A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-studyXinnate AB
- RECRUITINGPHASE1, PHASE2NCT07193134GMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentCHU de Quebec-Universite Laval · PI: Lucie Germain, PhD
- RECRUITINGPHASE1, PHASE2NCT06834035Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis BullosaM. Peter Marinkovich · PI: Matt P Marinkovich, MD
- RECRUITINGPhase 3NCT07016750A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis BullosaKrystal Biotech, Inc.
- RECRUITINGPhase 3NCT06917690A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaChiesi Farmaceutici S.p.A.
- ACTIVE NOT RECRUITINGPhase 3NCT06892639Evaluation of D-Fi for the Treatment of Wounds Due to DEBCastle Creek Biosciences, LLC.
- RECRUITINGNCT06423573A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving FilsuvezAmryt Pharma
- RECRUITINGPHASE1, PHASE2NCT04173650MSC EVs in Dystrophic Epidermolysis BullosaAegle Therapeutics · PI: David T Woodley, MD
- RECRUITINGNCT06563414A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)Krystal Biotech, Inc.
- ACTIVE NOT RECRUITINGPhase 1NCT06713434Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis BullosaFundación DEBRA Chile, Niños Piel de Cristal
- RECRUITINGNCT06177353Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in VitroAssistance Publique - Hôpitaux de Paris · PI: Reem Al-Daccak, Dr
- RECRUITINGPHASE1, PHASE2NCT07230223Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis BullosaIsfahan University of Medical Sciences · PI: Masoud Soleimani, Prof
- ACTIVE NOT RECRUITINGPhase 3NCT05725018A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsAbeona Therapeutics, Inc · PI: Angela Iheanacho, MS
- ACTIVE NOT RECRUITINGNCT05843994Artificial Intelligence Patient App for RDEB SCCsNorthwestern University
- RECRUITINGNCT04917887Long-Term Follow-up ProtocolKrystal Biotech, Inc.
- ACTIVE NOT RECRUITINGPhase 3NCT04213261A Study of FCX-007 for Recessive Dystrophic Epidermolysis BullosaCastle Creek Biosciences, LLC.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04186650Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent GraftsInstitut National de la Santé Et de la Recherche Médicale, France
- ACTIVE NOT RECRUITINGEarly Phase 1NCT04171661Self-Assembled Skin Substitute for the Treatment of Epidermolysis BullosaCHU de Quebec-Universite Laval
- RECRUITINGNCT01019148Characteristics of Patients With Recessive Dystrophic Epidermolysis BullosaStanford University · PI: Jean Tang, MD, PhD